Serum sarcosine is a risk factor for progression and survival in patients with metastatic castration-resistant prostate cancer

Author: Lucarelli Giuseppe   Ditonno Pasquale   Bettocchi Carlo   Spilotros Marco   Rutigliano Monica   Vavallo Antonio   Galleggiante Vanessa   Fanelli Margherita   Larocca Angela Maria Vittoria   Germinario Cinzia Annatea   Maiorano Eugenio   Selvaggi Francesco Paolo   Battaglia Michele  

Publisher: Future Medicine

ISSN: 1479-6694

Source: Future Oncology, Vol.9, Iss.6, 2013-06, pp. : 899-907

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content